MOTS-c Enters Phase 2a Human Trial for Prediabetes: What the Research Shows
MOTS-c — a peptide synthesized inside your own mitochondria — is now in Phase 2a human trials for prediabetes. Early data suggests it improves insulin sensitivity and metabolic flexibility without the side effects of pharmaceutical interventions.
MOTS-c — a peptide synthesized inside your own mitochondria — is now in Phase 2a human trials for prediabetes. Early data suggests it improves insulin sensitivity and metabolic flexibility without the side effects of pharmaceutical interventions.
Peptide South Africa Research Research TeamEditorial
#insulin-resistance#MOTS-C#mitochondria#prediabetes#metabolic health#longevity#Clinical TrialsShare this articleTwitterLinkedInTrack Your Peptide Protocols
Use Peptide South Africa Research to log injections, calculate doses, access our peptide library, and optimize your protocols.
Download Peptide South Africa ResearchExplore More Peptide ResourcesFree peptide calculators·Peptide research hub·Peptide glossary·Semaglutide guide·BPC-157 guide·Best peptide calculator
More in Peptide Science
Retatrutide Cuts Knee Pain by 75.8%: What the TRIUMPH-4 Trial Means Beyond Weight Loss
Everyone focused on the 71-pound weight loss stat from TRIUMPH-4. But the buried finding — 75.8% reduction in knee pain scores — may be the more important number for anyone living with joint pain.
BRP Peptide: Stanford's AI-Discovered 'Natural Ozempic' Explained
BRP Peptide: Stanford's AI-Discovered 'Natural Ozempic' Explained A Stanford AI tool screened 2,600 uncharacterized peptides and identified BRP — a 12-amino acid molecule that cuts food intake by up to 50%, promotes fat burning, and avoids the nausea, constipation, and muscle loss common with GLP-1 drugs. Here's wha…
Tesamorelin: The Science-Backed Growth Hormone Peptide for Fat Loss and Longevity
Tesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.